May 6th 2024
In an ambitious effort to address the ongoing uncertainty within the 340B Program space, 6 senators released a draft discussion bill earlier this year titled the SUSTAIN Act.
Background and Key Concepts in Biosimilars: Improving Awareness and Addressing Common Concerns
1.0 Credit / Law
View More
Clinical Conversations With the Cancer Care Team: Striving for Equitable Access to Oral Anticancer Medications
1.5 Credits / Law, Oncology
View More
Child Abuse: Responsibilities and Protection of the Reporter
1.0 Credit / Law
View More
Site-of-Care Optimization Under the Medical Benefit
June 15th 2013Michael Einodshofer, director, utilization management, Walgreens, describes how contractual methodologies and cost differences across various sites of service can influence how a specialty drug is reimbursed under the medical benefit.
Watch
Highlights from Magellan Pharmacy Solutions' 2012 Medical Pharmacy & Oncology Trend Report
March 13th 2013We sat down with Kjel A. Johnson, PharmD, senior vice president, Strategy & Business Development, Magellan Pharmacy Solutions, to learn more about buy-and-bill practices, 340b drug pricing, and how site-of-care changes may affect the drugs covered under the medical benefit.
Read More
Copay Organizations and Specialty Pharmacies: Partnering to Help Patients in Need
February 20th 2012Copay organizations play an important role in helping patients obtain their medications and have become integral partner with specialty pharmacies as they work together to support different therapies.
Read More